Recent research into retatrutide, a dual activator for GLP-1 and GIP receptors, are showing promising effects in treating weight gain and related 2 disease. Initial evidence suggest a novel mechanism contributing to https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/